1 Result: VirTra
VirTra Shines with Record-Breaking Revenue, Beam Global Beats Expectations, Eloxx Pharmaceuticals Misses Estimates, Ducommun Launches Public Offering
May 15th, 2023
VirTra, Inc. (Nasdaq: VTSI) achieved remarkable double-digit millions in quarterly revenue for the first time, surpassing expectations with Q1 2023 earnings per share (EPS) of $0.27 compared to the consensus estimate of $0.04. In after-hours tradi. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login